Works by Kunte, Sophie C.

Results: 13

FAP-Directed Imaging and Therapy in Head and Neck Cancer of Unknown Primary.

Published in:

Cancers, 2025, v. 17, n. 13, p. 2205, doi. 10.3390/cancers17132205

By:

Kunte, Sophie C.;
Sheikh, Gabriel T.;
Giesel, Frederik L.;
Canis, Martin;
Werner, Rudolf A.

Publication type:

Article

Feasibility of a single-day protocol for SPECT and PET assessment of dopamine transporter availability, cardiac innervation and metabolic patterns in patients with movement disorders.

Published in:

European Journal of Nuclear Medicine & Molecular Imaging, 2025, v. 52, n. 9, p. 3424, doi. 10.1007/s00259-025-07188-0

By:

Scheifele, Maximilian;
Gnörich, Johannes;
Schröder, Elisabeth;
Kunte, Sophie C.;
Ells, Zachary;
Hagen, Johannes;
Katzdobler, Sabrina;
Palleis, Carla;
Bernhardt, Alexander;
Jäck, Alexander;
Franzmeier, Nicolai;
Fischer, Maximilian;
Levin, Johannes;
Höglinger, Günter U.;
Werner, Rudolf A.;
Brendel, Matthias

Publication type:

Article

Evidence-Based Clinical Protocols to Monitor Efficacy of [177Lu]Lu-PSMA Radiopharmaceutical Therapy in Metastatic Castration-Resistant Prostate Cancer Using Real-World Data.

Published in:

Journal of Nuclear Medicine, 2025, v. 66, n. 7, p. 1054, doi. 10.2967/jnumed.124.269431

By:

Unterrainer, Lena M.;
De Leiris, Nicolas;
Unterrainer, Marcus;
Delker, Astrid;
Hempel, Linus;
Ells, Zachary;
Kunte, Sophie C.;
Zahner, Josef;
Holzgreve, Adrien;
Zacherl, Mathias J.;
Sheikh, Gabriel T.;
Casuscelli, Jozefina;
Leenhardt, Julien;
Pienta, Kenneth J.;
Jacquet, Emmanuelle;
Laramas, Mathieu;
Long, Jerome;
Faure, Marine;
Reboulet, Ghislaine;
Paller, Channing J.

Publication type:

Article

PSMA-Expression Is Highly Associated with Histological Subtypes of Renal Cell Carcinoma: Potential Implications for Theranostic Approaches.

Published in:

Biomedicines, 2023, v. 11, n. 11, p. 3095, doi. 10.3390/biomedicines11113095

By:

Bui, Vinh Ngoc;
Unterrainer, Lena M.;
Brendel, Matthias;
Kunte, Sophie C.;
Holzgreve, Adrien;
Allmendinger, Fabian;
Bartenstein, Peter;
Klauschen, Frederick;
Unterrainer, Marcus;
Staehler, Michael;
Ledderose, Stephan

Publication type:

Article

Total Tumor Volume on 18 F-PSMA-1007 PET as Additional Imaging Biomarker in mCRPC Patients Undergoing PSMA-Targeted Alpha Therapy with 225 Ac-PSMA-I&T.

Published in:

Biomedicines, 2022, v. 10, n. 5, p. 946, doi. 10.3390/biomedicines10050946

By:

Unterrainer, Lena M.;
Beyer, Leonie;
Zacherl, Mathias J.;
Gildehaus, Franz J.;
Todica, Andrei;
Kunte, Sophie C.;
Holzgreve, Adrien;
Sheikh, Gabriel T.;
Herlemann, Annika;
Casuscelli, Jozefina;
Brendel, Matthias;
Albert, Nathalie L.;
Wenter, Vera;
Schmidt-Hegemann, Nina-Sophie;
Kunz, Wolfgang G.;
Cyran, Clemens C.;
Ricke, Jens;
Stief, Christian G.;
Bartenstein, Peter;
Ilhan, Harun

Publication type:

Article

Kontinuierliche Glukosemessung bei Typ-2-Diabetes.

Published in:

MMW: Fortschritte der Medizin, 2025, v. 167, n. 10, p. 67, doi. 10.1007/s15006-025-4955-y

By:

Siegmund, Thorsten;
Kunte, Sophie C.

Publication type:

Article

FAPI PET for monitoring of rheumatological treatment in multifocal peritoneal nodular fibrosis: a case study.

Published in:

European Journal of Nuclear Medicine & Molecular Imaging, 2025, v. 52, n. 8, p. 2740, doi. 10.1007/s00259-024-07052-7

By:

Unterrainer, Lena M.;
Ledderose, Stephan T.;
Kunte, Sophie C.;
Toms, Johannes;
Cyran, Clemens C.;
Holzgreve, Adrien;
Unterrainer, Marcus;
Schulze-Koops, Hendrik

Publication type:

Article

PET/CT imaging of differentiated and medullary thyroid carcinoma using the novel SSTR-targeting peptide [18F]SiTATE – first clinical experiences.

Published in:

European Journal of Nuclear Medicine & Molecular Imaging, 2025, v. 52, n. 3, p. 900, doi. 10.1007/s00259-024-06944-y

By:

Kunte, Sophie C.;
Wenter, Vera;
Toms, Johannes;
Lindner, Simon;
Unterrainer, Marcus;
Eilsberger, Friederike;
Jurkschat, Klaus;
Wängler, Carmen;
Wängler, Björn;
Schirrmacher, Ralf;
Tiling, Maximilian W.;
Sheikh, Gabriel T.;
Mehrens, Dirk;
Brendel, Matthias;
Rübenthaler, Johannes;
Auernhammer, Christoph J.;
Spitzweg, Christine;
Unterrainer, Lena M.;
Holzgreve, Adrien

Publication type:

Article

[68 Ga]Ga-FAPI-46 PET/CT for locoregional lymph node staging in urothelial carcinoma of the bladder prior to cystectomy: initial experiences from a pilot analysis.

Published in:

European Journal of Nuclear Medicine & Molecular Imaging, 2024, v. 51, n. 6, p. 1786, doi. 10.1007/s00259-024-06595-z

By:

Unterrainer, Lena M.;
Eismann, Lennert;
Lindner, Simon;
Gildehaus, Franz-Josef;
Toms, Johannes;
Casuscelli, Jozefina;
Holzgreve, Adrien;
Kunte, Sophie C.;
Cyran, Clemens C.;
Menold, Paula;
Karl, Alexander;
Unterrainer, Marcus;
Ledderose, Stephan T.;
Stief, Christian G.;
Bartenstein, Peter;
Kretschmer, Alexander;
Schulz, Gerald B.

Publication type:

Article

Correction to: Next‑generation PET/CT imaging in meningioma—first clinical experiences using the novel SSTR‑targeting peptide [18F]SiTATE.

Published in:

2023

By:

Unterrainer, Marcus;
Kunte, Sophie C.;
Unterrainer, Lena M.;
Holzgreve, Adrien;
Delker, Astrid;
Lindner, Simon;
Beyer, Leonie;
Brendel, Matthias;
Kunz, Wolfgang G.;
Winkelmann, Michael;
Cyran, Clemens C.;
Ricke, Jens;
Jurkschat, Klaus;
Wängler, Carmen;
Wängler, Björn;
Schirrmacher, Ralf;
Belka, Claus;
Niyazi, Maximilian;
Tonn, Joerg‑Christian;
Bartenstein, Peter

Publication type:

Correction Notice

Next-generation PET/CT imaging in meningioma—first clinical experiences using the novel SSTR-targeting peptide [18F]SiTATE.

Published in:

European Journal of Nuclear Medicine & Molecular Imaging, 2023, v. 50, n. 11, p. 3390, doi. 10.1007/s00259-023-06315-z

By:

Unterrainer, Marcus;
Kunte, Sophie C.;
Unterrainer, Lena M.;
Holzgreve, Adrien;
Delker, Astrid;
Lindner, Simon;
Beyer, Leonie;
Brendel, Matthias;
Kunz, Wolfgang G.;
Winkelmann, Michael;
Cyran, Clemens C.;
Ricke, Jens;
Jurkschat, Klaus;
Wängler, Carmen;
Wängler, Björn;
Schirrmacher, Ralf;
Belka, Claus;
Niyazi, Maximilian;
Tonn, Joerg-Christian;
Bartenstein, Peter

Publication type:

Article

Measurable disease as baseline criterion for response assessment in glioblastoma: A comparison of PET -based (PET RANO 1.0) and MRI-based (RANO) assessments.

Published in:

Neuro-Oncology, 2025, v. 27, n. 1, p. 77, doi. 10.1093/neuonc/noae208

By:

Müller, Katharina J;
Forbrig, Robert;
Reis, Jonas;
Wiegand, Lilian;
Barci, Enio;
Kunte, Sophie C;
Kaiser, Lena;
Schönecker, Stephan;
Schichor, Christian;
Harter, Patrick N;
Thon, Niklas;
Baumgarten, Louisa von;
Preusser, Matthias;
Albert, Nathalie L

Publication type:

Article

Comparison of the Hematotoxicity of PRRT with Lutathera ® and Locally Manufactured 177 Lu-HA-DOTATATE in Patients with Neuroendocrine Tumors and the Impact of Different Application Intervals.

Published in:

Cancers, 2025, v. 17, n. 9, p. 1423, doi. 10.3390/cancers17091423

By:

Hofmann, Markus;
Kunte, Sophie C.;
Unterrainer, Marcus;
Delker, Astrid;
Holzgreve, Adrien;
Toms, Johannes;
Gildehaus, Franz Joseph;
Auernhammer, Christoph J.;
Spitzweg, Christine;
Zacherl, Mathias J.;
Ilhan, Harun;
Rübenthaler, Johannes;
Beyer, Leonie;
Unterrainer, Lena M.

Publication type:

Article

Works by Kunte, Sophie C.

FAP-Directed Imaging and Therapy in Head and Neck Cancer of Unknown Primary.

Feasibility of a single-day protocol for SPECT and PET assessment of dopamine transporter availability, cardiac innervation and metabolic patterns in patients with movement disorders.

Evidence-Based Clinical Protocols to Monitor Efficacy of [<sup>177</sup>Lu]Lu-PSMA Radiopharmaceutical Therapy in Metastatic Castration-Resistant Prostate Cancer Using Real-World Data.

PSMA-Expression Is Highly Associated with Histological Subtypes of Renal Cell Carcinoma: Potential Implications for Theranostic Approaches.

Total Tumor Volume on 18 F-PSMA-1007 PET as Additional Imaging Biomarker in mCRPC Patients Undergoing PSMA-Targeted Alpha Therapy with 225 Ac-PSMA-I&T.

Kontinuierliche Glukosemessung bei Typ-2-Diabetes.

FAPI PET for monitoring of rheumatological treatment in multifocal peritoneal nodular fibrosis: a case study.

PET/CT imaging of differentiated and medullary thyroid carcinoma using the novel SSTR-targeting peptide [<sup>18</sup>F]SiTATE – first clinical experiences.

[<sup>68 </sup>Ga]Ga-FAPI-46 PET/CT for locoregional lymph node staging in urothelial carcinoma of the bladder prior to cystectomy: initial experiences from a pilot analysis.

Correction to: Next‑generation PET/CT imaging in meningioma—first clinical experiences using the novel SSTR‑targeting peptide [<sup>18</sup>F]SiTATE.

Next-generation PET/CT imaging in meningioma—first clinical experiences using the novel SSTR-targeting peptide [<sup>18</sup>F]SiTATE.

Measurable disease as baseline criterion for response assessment in glioblastoma: A comparison of PET -based (PET RANO 1.0) and MRI-based (RANO) assessments.

Comparison of the Hematotoxicity of PRRT with Lutathera ® and Locally Manufactured 177 Lu-HA-DOTATATE in Patients with Neuroendocrine Tumors and the Impact of Different Application Intervals.